Amanote Research

Amanote Research

    RegisterSign In

Can We Prescribe TMP/SMX Prophylaxis Without Any Concerns Equally for All Patients With Rheumatic Disease?

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2018-213027
Full Text
Open PDF
Abstract

Available in full text

Categories
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
Date

February 6, 2018

Authors
Yasuhiro SuyamaMasato Okada
Publisher

BMJ


Related search

TMP-SMX Induced Aseptic Meningitis

Kansas Journal of Medicine
2008English

364 Phaemacokinetic Evaluation of Trimethoprim-Sulfameth-Oxazole(tmp-Smx) in Patients With Cystic Fibrosis(cf)

Pediatric Research
Child HealthPediatricsPerinatology
1981English

Approaches to Improving Adherence to Secondary Prophylaxis for Rheumatic Fever and Rheumatic Heart Disease

Cardiology in Review
MedicineCardiovascular MedicineCardiology
2016English

Can We Make Any Recommendations About Physical Activity and Peptic Ulcer Disease?

Western Journal of Medicine
2000English

Rheumatic Fever Prophylaxis.

BMJ
1967English

Stenotrophomonas Maltophilia: ResistĂȘncia Emergente Ao SMX-TMP Em Isolados Brasileiros. Uma Realidade?

Jornal Brasileiro de Patologia e Medicina Laboratorial
2011English

Can We All Just Get Along?

Nature Genetics
Genetics
2012English

All Bleeding Stops: How We Can Help...

Critical Care
Critical CareIntensive Care Medicine
2010English

Two Studies of Compliance With Daily Prophylaxis in Rheumatic Fever Patients in Iowa.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1980English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy